• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Targeted Anti-tumor Therapy
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Issue
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Times Cited
  • Citing Article List
  • Abstract
  • Keywords
  • Introduction
  • Chemistry of BD
  • Antineoplastic effects of BD in human malignancies
  • Anti-metastatic effects of BD
  • Potential anti-inflammatory effects of BD
  • Pharmacokinetics, toxicity and metabolism
  • Clinical application of BD
  • Conclusion and future directions
  • Abbreviations
  • Declarations
  • References

  • Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Medicinal chemistry advances in targeting class I histone deacetylases”.
    No. Publication Date Citing Article
    1 2024 Zhengyan Zhang, Yingying Tang, Yu Wang, Junyi Xu, Xiaotong Yang, Mingzhu Liu, Massimiliano Mazzone, Ningning Niu, Yongwei Sun, Yujie Tang, Jing Xue. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer, Advanced Science. 2024; 11: 2402244.  https://doi.org/10.1002/advs.202402244
    2 2024 Samima Khatun, Sk. Abdul Amin, Debasmita Choudhury, Boby Chowdhury, Tarun Jha, Shovanlal Gayen. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents, Expert Opinion on Drug Discovery. 2024; 19: 353.  https://doi.org/10.1080/17460441.2024.2305730
    3 2024 Mohammad-Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Mahsa Akbarzadeh. Histone deacetylase inhibitors for leukemia treatment: current status and future directions, European Journal of Medical Research. 2024; 29: 514.  https://doi.org/10.1186/s40001-024-02108-8
    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
    • Exploration of Targeted Anti-tumor Therapy
    • eISSN 2692-3114
    • etatjournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Neuroscience
    • Exploration of Digestive Diseases
    • Exploration of Musculoskeletal Diseases
    • Exploration of Drug Science
    • Exploration of Asthma & Allergy
    • Exploration of Foods and Foodomics
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of BioMat-X
    • Exploration of Endocrine and Metabolic Diseases
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2024 Open Exploration Publishing Inc.